Acadia Healthcare (NASDAQ:ACHC) Issues Earnings Results

Acadia Healthcare (NASDAQ:ACHC) released its quarterly earnings data on Wednesday. The company reported $0.72 EPS for the quarter, topping analysts’ consensus estimates of $0.71 by $0.01, FiscalAI reports. The company had revenue of $851.57 million for the quarter, compared to the consensus estimate of $852.43 million. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The company’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same period last year, the business posted $0.91 EPS. Acadia Healthcare updated its FY 2025 guidance to 2.350-2.450 EPS.

Acadia Healthcare Price Performance

Shares of ACHC stock opened at $20.26 on Friday. The firm has a fifty day moving average of $23.41 and a two-hundred day moving average of $22.79. The firm has a market cap of $1.87 billion, a P/E ratio of 13.42, a P/E/G ratio of 4.56 and a beta of 0.97. Acadia Healthcare has a 1-year low of $17.13 and a 1-year high of $47.08. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32.

Institutional Trading of Acadia Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of the company. EverSource Wealth Advisors LLC grew its position in shares of Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after acquiring an additional 497 shares in the last quarter. Prudential Financial Inc. lifted its stake in Acadia Healthcare by 21.9% during the second quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock worth $225,000 after purchasing an additional 1,780 shares during the last quarter. Arrowstreet Capital Limited Partnership acquired a new position in Acadia Healthcare in the second quarter worth $335,000. Corient Private Wealth LLC increased its stake in Acadia Healthcare by 55.6% during the second quarter. Corient Private Wealth LLC now owns 19,056 shares of the company’s stock valued at $432,000 after purchasing an additional 6,813 shares during the last quarter. Finally, Bayesian Capital Management LP acquired a new stake in shares of Acadia Healthcare during the second quarter worth $460,000.

Analyst Upgrades and Downgrades

ACHC has been the topic of several research reports. Bank of America lowered shares of Acadia Healthcare from a “buy” rating to a “neutral” rating and cut their price target for the company from $27.00 to $25.00 in a report on Wednesday, September 10th. Wall Street Zen upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Sunday, August 3rd. KeyCorp cut their price objective on Acadia Healthcare from $55.00 to $35.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 8th. Cowen reaffirmed a “buy” rating on shares of Acadia Healthcare in a research report on Thursday, August 7th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and set a $25.00 target price on shares of Acadia Healthcare in a report on Tuesday, October 7th. Eight equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $34.82.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.